TechNavio today launched its report Global Human Insulin Market 2011-2015 based on an in-depth study covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers’ understanding of the present and future landscape of the market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said; ”The Global Human Insulin market is currently experiencing significant growth in the APAC region, especially in certain countries such as China and India. China is considered to be one of the countries with the largest diabetic populations at present. The prevalence of diabetes in China increased significantly in 2010. Further, India is currently home to tremendous numbers of people suffering from diabetes. Hence, there is significantly high demand for human insulin in certain countries in the APAC region.”
According to the report, there is an increase in innovative biologic drug molecules that increase the demand for human insulin, which is eventually expected to drive the growth of the Global Human Insulin market during the forecast period.
Further, the risk of cancer associated with human insulin use is expected to be one of the main reasons for the decline of human insulin sales during the forecast period.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic reports on niche and emerging technologies. For further information, please visit whttp://goo.gl/5JRyO
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Report – Global Human Insulin Market 2011-2015
